Category Patents/Designs/Trade Secrets

US Congress Reconsiders Anti-Patent Troll Law

It happened again on 5 February. The powerful chair of the House Judiciary Committee, Rep. Bob Goodlatte introduced the Innovation Act for a second time. This bill, aimed at hurting patent trolls by making a plethora of changes in US patent law, easily passed the House of Representatives last term. It subsequently bogged down in a Democrat-controlled Senate. However, now that the GOP controls both wings of Congress, many observers predict the bill will have soon become law. Other experts aren’t so sure, noting that the Innovation Act is drawing some powerful opposition – and not just from patent trolls.

At WTO Next Week: GI Register, Plain Packaging, Women In Innovation

The next meeting of the World Trade Organization intellectual property committee is expected to include discussions on women and innovation, and concerns about legislative efforts in the United Kingdom and Ireland to introduce plan packaging for tobacco products. Prior to the meeting, informal consultations will be held on the negotiating issue of an international register for geographical indications (GIs) for wines and spirits.

United States, Japan To Join International Design System At WIPO

On 13 February, the United States and Japan will deposit their instruments of accession to the Geneva Act of July 2, 1999 (the Geneva Act) of the WIPO’s Hague Agreement Concerning the International Registration of Industrial Designs (the Hague Agreement). A ceremony will be held at the World Intellectual Property Organization, which manages the agreement.

US Challenges For Biotech In 2015 – An Interview With BIO’s Hans Sauer

The biotechnology industry is closely watching developments in the United States that could impact the industry in 2015. These include the regulatory framework for biosimilars, possible patent legislation, post-grant review procedure, and the consequences of the recent Supreme Court ruling banning the patenting of human genes. Hans Sauer, Deputy General Counsel for Intellectual Property at the Biotechnology Industry Organization (BIO), recently spoke with Intellectual Property Watch’s Catherine Saez. Sauer was asked to lay out the main developments to watch in the coming year.

Questions About Funding, Text Of Tufts Study On Drug Costs

The Union for Affordable Cancer Treatment has sent a letter to the author of a much-noted Tufts University (US) study that found high development costs for medicines, with copies to the university administration. The letter requests transparency on the funding of the study and the press conference announcing the results, as well as copies of the study itself, which the group says was not made public, along with details to justify the result.